New sporadic prion protein disease identified by Case Western Reserve

Variably protease-sensitive prionopathy shares genotype characteristics with Creutzfeldt-Jakob disease

A new sporadic prion protein disease has been discovered. Variably protease-sensitive prionopathy (VPSPr), as it has been named, is the second type of complete sporadic disease to be identified since Creutzfeldt-Jakob disease (CJD) was reported in the 1920s. The landmark finding from the National Prion Disease Pathology Surveillance Center at Case Western Reserve University is published in the August issue of Annals of Neurology.

Read more

Researchers find new piece of CJD puzzle

A new treatment route for bovine spongiform encephalopathy (BSE) and its human form Creutzfeldt Jakob disease (CJD) could be a step closer based on new results from scientists at the University of Leeds. The team has found that a protein called Glypican-1 plays a key role in the development of BSE. Details are published November 20 in the open-access journal PLoS Pathogens.

Read more

Cell study explains why younger people more at risk of vCJD

Specific cells within the immune system could help explain why younger people are more susceptible to variant CJD, scientists believe

Specific cells within the immune system could help explain why younger people are more susceptible to variant Creutzfeldt-Jakob Disease (CJD), scientists believe.

Read more